南新制药: 第二届监事会第十五次会议决议公告

Meeting Overview - The second session of the second Supervisory Board of Hunan Nanxin Pharmaceutical Co., Ltd. was held on August 27, 2025, via communication [1] - The meeting was convened in accordance with the Company Law, Securities Law, and the company's articles of association [1] Supervisory Board Resolutions - The Supervisory Board approved the proposal regarding the company's 2025 semi-annual report, confirming that the report's preparation and review processes complied with relevant laws and regulations, and the information presented was true, accurate, and complete [2] - The voting result for the semi-annual report was 3 votes in favor, 0 against, and 0 abstentions [2] Fund Usage Report - The Supervisory Board also approved the special report on the storage and usage of raised funds for the first half of 2025, affirming that the report complied with regulatory requirements and did not harm the interests of shareholders, especially minority shareholders [2] - The voting result for the fund usage report was also 3 votes in favor, 0 against, and 0 abstentions [2]